Reduced social and economic costs of acute or chronic disease or other health conditions.
Societal and financial cost of illness is manifested by general productivity losses, lesser quality of life, lowered resources, and other phenomena. New procedures, interventions, policies, and other benefits from translational science hold the potential to alleviate undue societal and community burden, provide opportunities for reallocation of resources, and increase quality of life.
Advice from authors on searching for information:
Determining measurable changes to the societal costs of illness from particular innovations in translational science are generally long-term or not directly observable. Researchers are encouraged to gather data early on the indirect costs of the condition(s) affected by shorter-term benefits such as patents or policies, and establish a routine of collecting data at fixed-time intervals to demonstrate societal impact.
Organizations, repositories, websites, and other sources where you can find more information:
Challenges you may encounter while searching for information:
Measurable changes to the societal costs of illness are not always directly observable. Societal cost of illness research by nature is focused on a specific disorder, disease, or condition such as depression, low back pain, or schizophrenia. Depending on the locale, organizations, and other administrative jurisdictional offices may collect and curate data on expenditures on specific disorders, diseases, or conditions which researchers can then analyze for changes. Data may not be available for all disorders, diseases, or conditions.
Articles, books, and other publications in translational science using the indicator: